[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354311-105":59,"doc-detail-354311-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","validation-of-a-cervical-cdo1celf4-methylation-test-for-endometrial-cancer-a-prospective-paired-sample-comparison-with-intrauterine-specimen","Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen","","Validation research evaluates a cervical CDO1/CELF4 DNA methylation assay for endometrial cancer and endometrial intraepithelial neoplasia (EIN). A prospective paired-samples study enrolled 226 women (July 2023–June 2024), collecting sequential noninvasive cervical brushing cells and invasive curettage specimens for comparative diagnostic performance. Individual CDO1, CELF4, and CISENDO methylation tests outperformed conventional markers, with significant 1Ct differences and strong cross-sample correlations. ROC results showed no accuracy difference between sampling types, supporting reliable, noninvasive triage potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/validation-of-a-cervical-cdo1celf4-methylation-test-for-endometrial-cancer-a-prospective-paired-sample-comparison-with-intrauterine-specimen/354311/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/validation-of-a-cervical-cdo1celf4-methylation-test-for-endometrial-cancer-a-prospective-paired-sample-comparison-with-intrauterine-specimen/354311.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s main goal?","Question",{"text":113,"@type":114},"To validate cervical CDO1/CELF4 gene methylation analysis for detecting EIN and endometrial cancer, and to compare diagnostic efficiency between cervical brushing cells and invasive curettage specimens.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were samples collected and compared?",{"text":118,"@type":114},"The study used a prospective paired-samples design, collecting sequential cervical brushing cells (CBCs) and diagnostic curettage (D&C) samples from each participant and comparing diagnostic performance and consistency.",{"name":120,"@type":111,"acceptedAnswer":121},"What diagnostic performance did the CISENDO test show?",{"text":122,"@type":114},"Using recommended cutoffs, CISENDO achieved an AUC of 0.929 with 93.5% sensitivity and 92.3% specificity from D&C samples, and an AUC of 0.916 from CBC samples, with no statistically significant difference between sampling types.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354311,1790377729,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":14,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 29 May 2026  \nDOI 10.3389/fmed.2026.1690020  \nOPEN ACCESS  \nEDITED BY  \nJinwei Miao,  \nCapital Medical University, China  \nREVIEWED BY  \nNayiyuan Wu,  \nCentral South University, China Serena Voccola,  \nConsorzio Sannio Tech, Italy  \n*CORRESPONDENCE  \nPingping Zhou  \n [137049713@qq.com](137049713@qq.com)[ ](137049713@qq.com)Yilin Li  \n [80325164@qq.com](80325164@qq.com)  \n†These authors have contributed equally to this work  \nRECEIVED 21 August 2025  \nREVISED 21 April 2026  \nACCEPTED 23 April 2026  \nPUBLISHED 29 May 2026  \nCITATION  \nCai B, Wang Y, Ma W, Wu Z, Yao T, Liu P, Wang L, Zhou P and Li Y (2026)  \nValidation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen. Front. Med. 13:1690020 .  \ndoi: 10.3389/fmed.2026.1690020  \nCOPYRIGHT  \n© 2026 Cai, Wang, Ma, Wu, Yao, Liu, Wang, Zhou and Li. This is an  \nopen-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nValidation of a cervical  \nCDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen  \nBingxin Cai1†, Yishan Wang2†, Wen Ma3 , Zhenzhen Wu1 , Tingting Yao1 , Pei Liu2 , Linhai Wang2 , Pingping Zhou1* and Yilin Li1*  \n1 Department of Obstetrics and Gynecology, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, China, 2 Department of Medical Laboratory, Beijing Origin-Poly Bio-Tec Co., Ltd., Beijing, China, 3 Law School of Chengdu University, Chengdu, China  \nBackground: The increasing global incidence of endometrial cancer (EC) underscores the urgent need for effective early detection. Noninvasive detection approaches, such as transvaginal ultrasonography (TVS), frequently exhibit low speciﬁcity, leading to a high rate of unnecessary invasive procedures. DNA methylation analysis has emerged as a promising noninvasive alternative. This study aimed to validate CDO1/CELF4 gene methylation analysis for detecting endometrial intraepithelial neoplasia (EIN) and EC and, critically, to compare its diagnostic efﬁcacy using noninvasive cervical brushing cells (CBCs) vs. invasive diagnostic curettage (D&C) samples.  \nMethods: A prospective paired-samples study was conducted at Gansu Provincial Maternity and Child Care Hospital (July 2023–June 2024), including 226 eligible women. CBC and D&C samples were collected sequentially from each participant and tested for CDO1/CELF4 methylation, with diagnostic performance and consistency compared between sample types.  \nResults: Among 226 participants, 31 were diagnosed with EIN or EC. Compared with conventional markers (cytology, endometrial thickness, and CA125 levels), individual CDO1, CELF4, and CISENDO (CDO1/CELF4) methylation tests from both CBC and D&C samples demonstrated superior diagnostic capabilities. Speciﬁcally, the 1Ct values of CDO1 and CELF4 were signiﬁcantly lower inpatients with EIN or EC than in those with benign lesions (P \u003C 0.0001 for all comparisons) . A strong positive correlation was observed between CBC and D&C samples for individual methylated CDO1 tests (R = 0 . 86) and CELF4 tests (R = 0 .78), suggesting a high agreement. ROC analysis conﬁrmed no statistically signiﬁcant difference in diagnostic accuracy between CBC and D&C samples for the CISENDO test (P = 0 . 244) . The CISENDO test achieved an AUC of 0 .929, with 93.5% sensitivity and 92.3% speciﬁcity using D&C samples, and an AUC of 0.916 with CBC samples when using manufacturer-recommended cutoff. Conclusion: CDO1/CELF4 methylation analysis in cervical brushing samples is a highly accurate and reliabl","cbCaipBDoct3LSU2","https://ap.wps.com/l/cbCaipBDoct3LSU2","pdf",4544069,12,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What was the study’s main goal?\",\"answer\":\"To validate cervical CDO1/CELF4 gene methylation analysis for detecting EIN and endometrial cancer, and to compare diagnostic efficiency between cervical brushing cells and invasive curettage specimens.\"},{\"question\":\"How were samples collected and compared?\",\"answer\":\"The study used a prospective paired-samples design, collecting sequential cervical brushing cells (CBCs) and diagnostic curettage (D\\u0026C) samples from each participant and comparing diagnostic performance and consistency.\"},{\"question\":\"What diagnostic performance did the CISENDO test show?\",\"answer\":\"Using recommended cutoffs, CISENDO achieved an AUC of 0.929 with 93.5% sensitivity and 92.3% specificity from D\\u0026C samples, and an AUC of 0.916 from CBC samples, with no statistically significant difference between sampling types.\"}]","Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen | PDF",1790110020,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/0a6fd3dbb78374eada663cfda6a05890.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/839d490d7875aff784c09cdfe2fe3336.webp",982,1388]